Umberto Vespasiani Gentilucci Selected Research

Umberto Vespasiani Gentilucci Research Topics

3	Fibrosis (Cirrhosis) 01/2022 - 12/2015
2	Disease Progression 01/2020 - 08/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2017 - 06/2002
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 12/2018
1	Cholestasis 08/2017
1	Autoimmune Diseases (Autoimmune Disease) 08/2017
1	Neoplasms (Cancer) 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Hepatic Encephalopathy 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Hepatitis 01/2005
1	Liver Diseases (Liver Disease) 01/2005
1	Anemia 06/2002
1	Asthenia 06/2002
1	Kidney Neoplasms (Kidney Cancer) 06/2002

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2017
1	Branched-Chain Amino AcidsIBA 01/2022
1	EnzymesIBA 01/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2018
1	Antiviral Agents (Antivirals)IBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 08/2017
1	Bile Acids and Salts (Bile Acids)IBA 08/2017
1	Alkaline PhosphataseIBA 08/2017
1	Reelin ProteinIBA 03/2017
1	SirtuinsIBA 01/2017
1	NAD (NADH)IBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	MetalsIBA 12/2015
1	AntioxidantsIBA 01/2005
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2005
1	Iloprost (Ventavis)FDA Link 01/2005
1	Interleukin-2 (IL2)IBA 06/2002

2	Therapeutics 01/2020 - 06/2002
1	Nutritional Support (Artificial Feeding) 01/2022
1	Enzyme Replacement Therapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2015
1	Immunotherapy 06/2002